Management of psoriasis patients with hepatitis B or hepatitis C virus infection

Table 4 Diagnosis and laboratory characteristics of reported psoriatic patients with chronic hepatitis B virus infection treated with tumor necrosis factor-α inhibitors

Ref.	Diagnosis, n	Concomitant HCV therapy, n	ALT outcomes at last follow-up compared to baseline, n	HCV viral load outcome at last follow-up compared to baseline, n
Khanna et al[80]	PsA, 1	1 (N/A)	1 (N/A)	1 (N/A)
Magliocco et al[81]	PsA, 3	0	3 (=)	2 (↓); 1(N/A)
Cecchi et al[82]	PsO, 1	0	1 (=)	1 (=)
De Simone et al[83]	PsO, 2	0	2 (=)	2 (↓)
Asladinis et al[84]	PsA, 1	0	1 (=)	1 (↓)
Rokshar et al[85]	PsO, 1	0	1 (N/A)	1 (=)
Pitarch et al[86]	PsA, 1	1 (N/A)	1 (=)	1 (N/A)
Linadarki et al[87]	PsA, 1	0	1 (=)	1 (=)
Alcaide et al[88]	PsO, 1	0	1 (=)	1 (=)
Piccolo et al[89]	PsO, 1	0	1 (↑)	1 (↓)
Collazzo et al[90]	PsO, 1	0	1 (=)	1 (N/A)
Cassano et al[91]	PsO, 1	0	1 (=)	1 (=)
Cavazzana et al[92]	PsA, 1	0	1 (=)	1 (=)
Behnam et al[93]	PsO, 1	1 (IFN + Rib)	1 (↓)	1 (↓)
Ventura et al[94]	PsO, 1; PsA, 1	0	2 (↓)	1 (↑); 1 (↓)
Paradisi et al[95]	PsA, 2	0	2 (=)	2 (=)
Prignano et al[96]	PsO, 1	0	1 (N/A)	1 (=)
Richetta et al[97]	PsO, 11	0	1 (N/A)	1 (N/A)
Garavaglia et al[98]	PsO, 3; PsA, 2	1 (IFN + Rib)	1 (=); 4 (↓)	3 (=); 1 (↓)
Gandhi et al[99]	PsO, 1	0	1 (↓)	1 (↓)
Di Lernia et al[100]	PsO, 13	0	1 (=)	1 (=)
Zanni et al[101]	PsA, 3	0	3 (=)4	3 (=)
Prignano et al[48]	PsO, 6	0	6 (=)	6 (=)
Mederacke et al[102]	PsA, 1	1 (IFN + Rib)	1 (N/A)	1 (↓)
Navarro et al[53]	PsO, 202	3 (IFN + Rib)	See references	See references
Bartalesi et al[103]	PsO, 1	1 (IFN + Rib)	1 (↓)	1 (↓)
Costa L et al[104]	PsA, 15	0	13 (=); 2 (↓)	14 (=); 1 (↓)
Di Nuzzo et al[105]	PsA, 2	1 (IFN + Rib)	1 (=); 1 (↓)	2 (↓)
Salvi et al[106]	PsO, 1	0	1 (↑)	1 (=)

¹1 erythrodermic psoriasis;

²1 erythrodermic psoriasis, 2 palmoplantar psoriasis;

³1 palmoplantar psoriasis;

⁴1 patient with concomitant alcoholic hepatitis. PsO: Psoriasis; PsA: Psoriatic arthritis; =: No significant change; ↓: Decreased; ↑: Increased; N/A: Not available; IFN: Interferon; Rib: Ribavirine.